Botulinum toxin A complex exploits intestinal M cells to enter the host and exert neurotoxicity

To cause food-borne botulism, botulinum neurotoxin (BoNT) in the gastrointestinal lumen must traverse the intestinal epithelial barrier. However, the mechanism by which BoNT crosses the intestinal epithelial barrier remains unclear. BoNTs are produced along with one or more non-toxic components, with which they form progenitor toxin complexes (PTCs). Here we show that serotype A1 L-PTC, which has high oral toxicity and makes the predominant contribution to causing illness, breaches the intestinal epithelial barrier from microfold (M) cells via an interaction between haemagglutinin (HA), one of the non-toxic components, and glycoprotein 2 (GP2). HA strongly binds to GP2 expressed on M cells, which do not have thick mucus layers. Susceptibility to orally administered L-PTC is dramatically reduced in M-cell-depleted mice and GP2-deficient (Gp2−/−) mice. Our finding provides the basis for the development of novel antitoxin therapeutics and delivery systems for oral biologics.

[1]  Kaoru Inoue,et al.  Structural analysis by X-ray crystallography and calorimetry of a haemagglutinin component (HA1) of the progenitor toxin from Clostridium botulinum. , 2003, Microbiology.

[2]  N. Mantis,et al.  Collaboration of epithelial cells with organized mucosal lymphoid tissues , 2001, Nature Immunology.

[3]  H. Kiyono,et al.  Comprehensive Gene Expression Profiling of Peyer’s Patch M Cells, Villous M-Like Cells, and Intestinal Epithelial Cells1 , 2008, The Journal of Immunology.

[4]  S. Fukuoka,et al.  GP2/THP gene family of self-binding, GPI-anchored proteins forms a cluster at chromosome 7F1 region in mouse genome. , 2004, Biochemical and biophysical research communications.

[5]  R. Jin,et al.  Assembly and function of the botulinum neurotoxin progenitor complex. , 2013, Current topics in microbiology and immunology.

[6]  H. Kiyono,et al.  Transcription factor Spi-B–dependent and –independent pathways for the development of Peyer’s patch M cells , 2012, Mucosal Immunology.

[7]  J. Molgó,et al.  Preferential Entry of Botulinum Neurotoxin A Hc Domain through Intestinal Crypt Cells and Targeting to Cholinergic Neurons of the Mouse Intestine , 2012, PLoS pathogens.

[8]  K. Kitadokoro,et al.  Crystal Structure of Clostridium botulinum Whole Hemagglutinin Reveals a Huge Triskelion-shaped Molecular Complex* , 2013, The Journal of Biological Chemistry.

[9]  M. Dorner,et al.  Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex , 2014, Science.

[10]  Philip K. Russell,et al.  Botulinum toxin as a biological weapon: medical and public health management. , 2001, JAMA.

[11]  K. Inoue,et al.  The haemagglutinin of Clostridium botulinum type C progenitor toxin plays an essential role in binding of toxin to the epithelial cells of guinea pig small intestine, leading to the efficient absorption of the toxin. , 1997, Microbiology.

[12]  A. B. Maksymowych,et al.  Pure Botulinum Neurotoxin Is Absorbed from the Stomach and Small Intestine and Produces Peripheral Neuromuscular Blockade , 1999, Infection and Immunity.

[13]  A. Hauschild.  Clostridium botulinum toxins. , 1990, International journal of food microbiology.

[14]  I. Williams,et al.  M cell-depletion blocks oral prion disease pathogenesis , 2012, Mucosal Immunology.

[15]  N A Mabbott,et al.  Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium , 2013, Mucosal Immunology.

[16]  M. Takeichi,et al.  Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin , 2010, The Journal of cell biology.

[17]  G. Schiavo,et al.  Neurotoxins affecting neuroexocytosis. , 2000, Physiological reviews.

[18]  Y. Fujinaga,et al.  Functional Dissection of the Clostridium botulinum Type B Hemagglutinin Complex: Identification of the Carbohydrate and E-Cadherin Binding Sites , 2014, PloS one.

[19]  A. B. Maksymowych,et al.  Structural Features of the Botulinum Neurotoxin Molecule That Govern Binding and Transcytosis across Polarized Human Intestinal Epithelial Cells , 2004, Journal of Pharmacology and Experimental Therapeutics.

[20]  D. Lacy,et al.  Molecular assembly of botulinum neurotoxin progenitor complexes , 2013, Proceedings of the National Academy of Sciences.

[21]  Philip Sutton,et al.  Mucin dynamics and enteric pathogens , 2011, Nature Reviews Microbiology.

[22]  Lei Jin,et al.  Structure of a Bimodular Botulinum Neurotoxin Complex Provides Insights into Its Oral Toxicity , 2013, PLoS pathogens.

[23]  Shunsuke Kimura,et al.  Uptake through glycoprotein 2 of FimH+ bacteria by M cells initiates mucosal immune response , 2009, Nature.

[24]  C. Shoemaker,et al.  Botulinum Neurotoxin Is Shielded by NTNHA in an Interlocked Complex , 2012, Science.

[25]  M. Vey,et al.  Studies on the dissociation of botulinum neurotoxin type A complexes. , 2011, Toxicon : official journal of the International Society on Toxinology.

[26]  A. B. Maksymowych,et al.  Binding and Transcytosis of Botulinum Neurotoxin by Polarized Human Colon Carcinoma Cells* , 1998, The Journal of Biological Chemistry.

[27]  M. Popoff,et al.  Receptor‐mediated transcytosis of botulinum neurotoxin A through intestinal cell monolayers , 2007, Cellular microbiology.

[28]  M. Popoff,et al.  Identification and characterization of functional subunits of Clostridium botulinum type A progenitor toxin involved in binding to intestinal microvilli and erythrocytes , 2000, FEBS letters.

[29]  W. Lencer,et al.  The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption , 2007, Cellular microbiology.

[30]  J. Mestecky,et al.  Enhancing Oral Vaccine Potency by Targeting Intestinal M Cells , 2010, PLoS pathogens.

[31]  S. Michie,et al.  Absence of the Major Zymogen Granule Membrane Protein, GP2, Does Not Affect Pancreatic Morphology or Secretion* , 2004, Journal of Biological Chemistry.

[32]  Yingji Jin,et al.  Disruption of the epithelial barrier by botulinum haemagglutinin (HA) proteins - differences in cell tropism and the mechanism of action between HA proteins of types A or B, and HA proteins of type C. , 2009, Microbiology.

[33]  R Weltzin,et al.  Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting , 1996, The Journal of experimental medicine.

[34]  D. Cavallone,et al.  Tamm-Horsfall glycoprotein: biology and clinical relevance. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[35]  M. Popoff,et al.  Differential entry of botulinum neurotoxin A into neuronal and intestinal cells , 2009, Cellular microbiology.

[36]  K. Takeshi,et al.  Molecular composition of Clostridium botulinum type A progenitor toxins , 1996, Infection and immunity.

[37]  H. Kiyono,et al.  RANKL Is Necessary and Sufficient to Initiate Development of Antigen-Sampling M Cells in the Intestinal Epithelium1 , 2009, The Journal of Immunology.